dr. pishvaian on fda approval of atezolizumab plus bevacizumab in hcc
Published 5 years ago • 117 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
3:40
daneng li, md, discusses the recent fda approval of combining atezolizumab bevacizumab in hcc
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
2:40
key outcomes of the phase 1b of atezolizumab and bevacizumab for advanced hcc
-
2:19
dr. arend on fda approval of frontline bevacizumab in ovarian cancer
-
3:58
atezolizumab and bevacizumab for upfront unresectable hcc
-
1:27
fda approval of atezolizumab for nsclc
-
2:32
atezolizumab and bevacizumab's function in treating liver cancer
-
48:56
daan paget: separating evs from plasma of healthy donors and mi patients
-
10:49
第四集 標靶免疫雙藥合一 晚期肝癌一線治療大突破
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
0:32
will atezolizumab and bevacizumab be the new soc in high-risk hcc?
-
0:13
copy of dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
0:37
combination atezolizumab plus bevacizumab improved quality of life in hcc
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
0:36
nevena damjanov, md, on the outcomes of combining atezolizumab with bevacizumab in hcc patients
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:09
ahmed kaseb, md, considers the effectiveness of bevacizumab atezolizumab in hcc
-
4:23
howard hochster, md, on whether atezolizumab bevacizumab regimen is a new standard in care in hcc
-
1:26
dr. pishvaian on implications of entrectinib study in pancreatic cancer